Digitising alpha therapeutics production
28/07/2026
PETra brings automation to pioneering 225Ac radiopharmaceutical development
LabLogic’s PETra Laboratory Information Management System has been adopted by manufacturers working with novel alpha-emitting radionuclides such as 225Ac to manage production and Quality Control, supporting the development pipeline from research through to commercialisation.
PETra has been specifically designed to support the unique requirements of GMP radiopharmaceutical manufacturing, helping facilities developing alpha therapeutics improve data integrity, automate practices and reduce reliance on manual processes.
The risks posed by using paper records in alpha therapeutics
Despite rapid advances in radiopharmaceutical development, many manufacturing facilities still rely on paper records and spreadsheets to document production and QC. These manual processes require extensive transcription, increasing the risk of human error and making data review both time-consuming and resource intensive.
For manufacturers working with novel alpha-emitting radionuclides such as 225Ac, the consequences of transcription or calculation errors are even greater. Ensuring the integrity of QC data is essential for patient safety, regulatory compliance and successful product development.
Eliminating manual transcription in radiopharmaceutical development
A key driver for adopting digital manufacturing solutions such as PETra is the need to eliminate manual transcription throughout its batch records and QC processes, reducing opportunities for error while ensuring decisions are based entirely on objective data.
PETra's calculation engine automatically captures instrument data, performs calculations, carries out quality checks in real-time, and manages unit conversions without manual intervention. The system also supports standard mathematical functions including averages, standard deviation, concentrations, yields and elapsed time alongside configurable text fields, checkboxes and custom calculations.
Built for GMP radiopharmaceutical production
Facilities with GMP certification require a digital solution designed around regulatory compliance. PETra was developed specifically for GMP radiopharmaceutical manufacturing, providing complete electronic batch records while maintaining full traceability and data integrity throughout production.
Unlike many digital systems that rely solely on PDF parsing, PETra interfaces directly with laboratory instruments wherever possible, significantly reducing the need for manual handling of analytical results.
Direct instrument interfacing
PETra communicates directly with a wide range of equipment already used throughout production and quality control, including HPLCs, radio-TLC systems, gas chromatographs, pH meters, gamma counters, dose calibrators and other analytical instruments from leading manufacturers including Agilent, Hidex and Mirion.
Direct instrument integration delivers superior data integrity compared with manual transcription or PDF-only workflows, providing an additional level of confidence that is particularly valuable in GMP manufacturing environments. PDF parsing remains available for instruments where direct interfacing is not possible.
Futureproofing the production of alpha therapeutics
As demand for alpha-emitting radiopharmaceuticals continues to increase, manufacturers require digital infrastructure that can support increasingly complex production processes while maintaining regulatory compliance.
PETra provides a futureproofed platform for organisations developing alpha therapeutics, helping to improve efficiency, reduce operational risk and establish robust digital workflows that can scale from research and development through to commercial manufacturing.
A new subscription model for PETra
To make digital transformation more accessible, LabLogic now offers PETra through a subscription model, allowing organisations to incorporate the system into operational expenditure rather than requiring significant upfront capital investment.
For organisations developing the next generation of alpha therapeutics, PETra provides a proven platform to improve efficiency, reduce risk and support compliant manufacturing.
Find out more
You can learn more about PETra by clicking the button below to speak to a product specialist directly to request a guided demonstration.